Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$1.67 - $2.77 $41,750 - $69,250
-25,000 Reduced 50.0%
25,000 $69,000
Q2 2021

Aug 13, 2021

BUY
$9.04 - $14.19 $451,999 - $709,500
50,000 New
50,000 $505,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $324M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Lombard Odier Asset Management (Usa) Corp Portfolio

Follow Lombard Odier Asset Management (Usa) Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.